Data supplements
Online Appendices
Online Appendices
Files in this Data Supplement:
- Appendix 1: DPP-4 inhibitor and pancreatitis warnings
- Reviewer Comments
- Original Submission
- STROBE Statement
- Appendix 2: Coding definitions for demographic and comorbid conditions
- Appendix 3: Coding definitions for hospital presentation with pancreatitis
- Appendix 4: Propensity score variables
- Appendix 5: Health care utilization prior to and after propensity weighting in patients initiated on sitagliptin or an alternative hypoglycemic agent
- Appendix 6: Ninety-day risk of a hospital encounter with acute pancreatitis for patients accrued after June 2011
- Appendix 7: Proportion of sitagliptin and alternative hypoglycemic agent users with at least one amylase or lipase test during 90 days of follow-up
- Appendix 8: Proportion of new sitagliptin, sulfonylurea, metformin and insulin users with acute pancreatitis at 90 days
- Appendix 9: Proportion of sitagliptin and alternative hypoglycemic agent monotherapy and combination therapy users with acute pancreatitis at 90 days